Nateglinide Type of group

OPEN MULTICENTRIC STUDY TO EVALUATE THE EFFECTS ON POSTPANDRIAL GLUCEMIA AT 2 HOURS AND THE TOLERABILITY OF THE ADMINISTRATION OF NATEGLINIDA 120 MG BEFORE EACH MAIN MEAL IN PATIENTS WITH DIABETES MELLITUS TYPE 2 UNDICTEDLY CONTROLLED WITH DIET

MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROL, WITH FORCED TITRATION, FACTORIAL DESIGN OF 2 X 2, TO EVALUATE THE EFFICACY AND SAFETY OF THE LONG-TERM ADMINISTRATION OF NATEGLINIDA AND VALSARTAN IN THE PREVENTION OF DIABETES AND DISORDERS CARDIOVASCULARS IN SUBJECTS WITH GLUCOSE DEFICIENT TOLERANCE (IGT).